logo
Sign in

MTNB Stock Price, Chart, Stats & News

Matinas BioPharma Holdings, Inc.
Save

Matinas BioPharma Holdings, Inc. (MTNB) does not currently pay a dividend.

1.53M
Market cap
Current P/E
Forward P/E

MTNB chart

1M
3M
1Y
5Y
Loading chart...

About

Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts. This sophisticated LNC delivery system leverages lipid nano-crystals to transport a diverse array of therapeutic agents, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.

Similar securities

Based on sector and market capitalization

Report issue